Clinical application of personalized biodegradable anastomotic stent via preoperative intestinal three-dimensions reconstruction in laparoscopic resection of rectal cancer
World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)
DOI: 10.4240/wjgs.122155 ↗Abstract
BACKGROUND Anastomotic complications affect postoperative recovery in patients with rectal cancer; therefore, more effective treatment strategies are urgently needed. AIM To analyze the clinical value of personalized biodegradable anastomotic reinforcement stents based on preoperative three-dimensional (3D) reconstruction parameters of the intestinal tract in laparoscopic anterior resection for rectal cancer. METHODS A total of 82 patients with rectal cancer who were admitted to our hospital between March 2023 and May 2025 were enrolled and divided into control and study groups according to the order of surgery. Both groups underwent laparoscopic anterior resection of the rectal cancer. The control group underwent conventional anastomosis, whereas the study group underwent implantation of personalized biodegradable anastomotic reinforcement stents based on the preoperative 3D reconstruction parameters of the intestinal tract. Perioperative indicators, postoperative recovery, anastomosis-related complications, postoperative inflammatory response levels and follow-up outcomes were compared between the two groups. RESULTS The stoma duration was longer in the study group than in the control group (P < 0.05). There were no significant differences in intraoperative blood loss, number of dissected lymph nodes, or conversion rate to open surgery between the two groups (P > 0.05). The time to first bowel sound recovery, time to first flatus, time to first oral intake, and time to first ambulation were shorter in the study group than in the control group (P < 0.05). The total incidence of anastomosis-related complications in the study group was 4.88% (2/41), which was lower than 21.95% (9/41) in the control group, with a significant difference (P < 0.05). The levels of inflammatory indicators at 1 day and 3 days after surgery in the study group were lower than those in the control group (P < 0.05). The Wexner incontinence and low anterior resection syndrome scores at 6 months and 12 months after surgery were significantly lower in the study group than in the control group (P < 0.05). CONCLUSION Implantation of personalized biodegradable anastomotic reinforcement stents based on preoperative 3D reconstruction parameters of the intestinal tract can promote postoperative intestinal function recovery, reduce the risk of anastomosis-related complications and inflammatory stimulation, and simultaneously improve postoperative defecation and anal function in patients undergoing laparoscopic anterior resection of rectal cancer.
EUVIMED